SEC Form 4 · accession 0001179110-17-011954
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric A Rose M.D.
Director
Period of report
Aug 30, 2017
Accepted (ET)
Sep 1, 2017 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 par value | Aug 30, 2017 | M | 982 | $7.67 | A | 13,634 | D | |
| Common Stock, $.01 par valueF2 | Aug 30, 2017 | S | 982 | $145.1672 | D | 12,652 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.67 | Aug 30, 2017 | M | 982 | D | Aug 12, 2010 | Aug 12, 2019 | Common Stock | 12,000 | 0 | D |
Explanation of responses
- F1Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F2This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $145.0000 and $145.4300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.